Genes related to growth and invasiveness are repressed by sodium butyrate in ovarian carcinoma cells
1996

Sodium Butyrate Represses Cancer-Related Genes in Ovarian Carcinoma Cells

publication Evidence: moderate

Author Information

Author(s): G Krupitzal, S Grill, H Harant, W Hulla, T Szekeres, H Huber, C Dittrich

Primary Institution: University of Vienna

Hypothesis

We wanted to investigate NaB-mediated interference on signals contributing to the expression of pradl, plau and gas6.

Conclusion

Sodium butyrate effectively down-regulates the expression of cancer-related genes in ovarian carcinoma cells.

Supporting Evidence

  • Sodium butyrate treatment led to significant morphological changes in ovarian carcinoma cells.
  • The expression of cyclin D1 and plasminogen activator-urokinase was suppressed by sodium butyrate.
  • Fibronectin expression increased significantly in response to sodium butyrate treatment.

Takeaway

Sodium butyrate is a substance that can help stop cancer cells from growing by changing how certain genes work.

Methodology

N.1 ovarian carcinoma cells were treated with sodium butyrate, and gene expression was analyzed using Northern blotting.

Limitations

The effects of sodium butyrate on gene expression may not be specific and could vary with different conditions.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication